About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CVRS
CUSIPN/A
Phone+1-508-6533335
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-323.84%
Return on Equity-110.93%
Return on Assets-88.11%
Miscellaneous
EmployeesN/A
Outstanding Shares188,770,000
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions
What is Corindus Vascular Robotics' stock symbol?
Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."
How were Corindus Vascular Robotics' earnings last quarter?
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) issued its earnings results on Wednesday, March, 14th. The medical equipment provider reported ($0.04) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.01. The medical equipment provider had revenue of $4.19 million for the quarter, compared to the consensus estimate of $3.90 million. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%. View Corindus Vascular Robotics' Earnings History.
What price target have analysts set for CVRS?
2 brokerages have issued 12-month target prices for Corindus Vascular Robotics' stock. Their forecasts range from $2.00 to $3.00. On average, they anticipate Corindus Vascular Robotics' share price to reach $2.50 in the next twelve months. View Analyst Ratings for Corindus Vascular Robotics.
Are investors shorting Corindus Vascular Robotics?
Corindus Vascular Robotics saw a decline in short interest in April. As of April 13th, there was short interest totalling 13,149,833 shares, a decline of 2.1% from the March 30th total of 13,438,496 shares. Based on an average trading volume of 688,500 shares, the days-to-cover ratio is presently 19.1 days. Currently, 15.0% of the company's stock are short sold.
Who are some of Corindus Vascular Robotics' key competitors?
Who are Corindus Vascular Robotics' key executives?
Corindus Vascular Robotics' management team includes the folowing people:
- Mr. Mark J. Toland, Pres, CEO & Director (Age 48)
- Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 48)
- Mr. Stephen Jeff Lemaster, Sr. VP & GM of Peripheral Intervention Segment (Age 47)
- Mr. Tal Wenderow, Co-Founder and Exec. VP of International & Bus. Devel.
- Mr. Doug Teany, Sr. VP of R&D and Operations
Has Corindus Vascular Robotics been receiving favorable news coverage?
Headlines about CVRS stock have been trending somewhat positive on Wednesday, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Corindus Vascular Robotics earned a news impact score of 0.01 on Accern's scale. They also assigned news articles about the medical equipment provider an impact score of 45.02 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Corindus Vascular Robotics?
Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Corindus Vascular Robotics' stock price today?
One share of CVRS stock can currently be purchased for approximately $1.12.
How big of a company is Corindus Vascular Robotics?
Corindus Vascular Robotics has a market capitalization of $272.68 million.
How can I contact Corindus Vascular Robotics?
Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.
MarketBeat Community Rating for Corindus Vascular Robotics (CVRS)
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Corindus Vascular Robotics in the last 12 months. Their average twelve-month price target is $2.50, suggesting that the stock has a possible upside of 123.21%. The high price target for CVRS is $3.00 and the low price target for CVRS is $2.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $2.50 | $2.50 | $3.00 | $3.00 |
| Price Target Upside: | 123.21% upside | 82.48% upside | 80.72% upside | 80.72% upside |
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Consensus Price Target History
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 3/15/2018 | Cowen | Set Price Target | Buy | $2.00 |  |
| 5/15/2017 | B. Riley | Reiterated Rating | Buy | $3.00 | |
(Data available from 4/25/2016 forward)
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Earnings History and Estimates Chart
Corindus Vascular Robotics (NYSEAMERICAN CVRS) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/14/2018 | Q4 2017 | ($0.0350) | ($0.04) | $3.90 million | $4.19 million | View | Listen | |
| 11/7/2017 | Q3 2017 | ($0.05) | ($0.04) | $3.60 million | $2.43 million | View | N/A | |
| 8/8/2017 | Q2 2017 | ($0.05) | ($0.04) | $3.10 million | $2.26 million | View | Listen | |
| 5/9/2017 | Q1 2017 | ($0.05) | ($0.07) | $1.59 million | $0.78 million | View | Listen | |
| 3/15/2017 | Q4 2016 | ($0.07) | ($0.0820) | $0.73 million | $0.54 million | View | N/A | |
| 11/8/2016 | Q316 | ($0.06) | ($0.07) | $1.27 million | $0.69 million | View | Listen | |
| 8/4/2016 | Q2 2016 | ($0.06) | ($0.06) | $1.20 million | $0.51 million | View | N/A | |
| 5/5/2016 | Q1 2016 | ($0.06) | ($0.06) | $0.90 million | $1.11 million | View | N/A | |
| 3/8/2016 | Q415 | ($0.05) | ($0.06) | $0.62 million | $0.83 million | View | N/A | |
| 11/12/2015 | Q315 | ($0.06) | ($0.06) | $0.70 million | $0.21 million | View | Listen | |
(Earnings results data provided by Zacks Investment Research)
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Corindus Vascular Robotics (NYSEAMERICAN CVRS) Insider Trading and Institutional Ownership History
Corindus Vascular Robotics (NYSEAMERICAN CVRS) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/13/2017 | Louis A Cannon | Director | Buy | 23,801 | $0.81 | $19,278.81 | | |
| 3/22/2017 | Louis A Cannon | Director | Buy | 27,000 | $1.30 | $35,100.00 | | |
| 2/28/2017 | Healthcor Management, L.P. | Major Shareholder | Buy | 7,557,436 | $0.66 | $4,987,907.76 | | |
| 11/25/2016 | Jeffrey Gold | Director | Buy | 10,000 | $0.76 | $7,600.00 | 9,098 | |
(Data available from 1/1/2013 forward)
Corindus Vascular Robotics (NYSEAMERICAN CVRS) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Corindus Vascular Robotics (CVRS) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - April 25 at 1:44 AM |
| Corindus Vascular Robotics (CVRS) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - April 17 at 10:55 PM |
| Corindus Vascular Robotics (CVRS) Downgraded to "Hold" at BidaskClub
www.americanbankingnews.com - April 16 at 8:40 PM |
 | BRIEF-Corindus Vascular Robotics Offering, Resale By Selling Stockholders Of Up To 40.8 Mln Shares Of Common ...
www.reuters.com - April 13 at 4:22 PM |
| Corindus Vascular Robotics (CVRS) Lifted to Hold at BidaskClub
www.americanbankingnews.com - April 11 at 3:58 PM |
| Corindus Vascular Robotics (CVRS) Given a $3.00 Price Target at Cowen
www.americanbankingnews.com - April 11 at 1:21 PM |
| Corindus Vascular Robotics (CVRS) Short Interest Down 5.2% in March
www.americanbankingnews.com - April 11 at 2:04 AM |
| Corindus Vascular Robotics (CVRS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 10 at 9:45 AM |
| Corindus Vascular Robotics (CVRS) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:27 PM |
| Corindus Vascular Robotics (CVRS) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - April 8 at 9:37 AM |
| Corindus Vascular Robotics (CVRS) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 7 at 3:19 PM |
| Short Interest in Corindus Vascular Robotics Inc (CVRS) Declines By 0.1%
www.americanbankingnews.com - March 28 at 1:40 AM |
 | Corindus Vascular Robotics (CVRS) Announces $25M Private Placement of Series A Convertible Preferred Shares, Warrants
www.streetinsider.com - March 16 at 5:17 PM |
 | The Corindus Vascular Robotics Inc. Roller Coaster Hits Another Upswing. Here's Why
finance.yahoo.com - March 16 at 5:17 PM |
 | Corindus Vascular Robotics (CVRS) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
seekingalpha.com - March 15 at 4:48 PM |
| Corindus Vascular Robotics (CVRS) Given a $2.00 Price Target at Cowen
www.americanbankingnews.com - March 15 at 3:44 PM |
| Corindus Vascular Robotics (CVRS) Releases Quarterly Earnings Results, Hits Estimates
www.americanbankingnews.com - March 15 at 1:20 PM |
| Corindus Vascular Robotics' (CVRS) CEO Mark Toland on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - March 15 at 9:32 AM |
| Corindus Vascular Robotics EPS in-line, beats on revenue
seekingalpha.com - March 14 at 5:32 PM |
 | Here's Why Corindus Vascular Robotics Inc. Is Surging Today
www.msn.com - March 14 at 5:32 PM |
| Here's Why Corindus Vascular Robotics Inc. Is Surging Today
finance.yahoo.com - March 14 at 5:32 PM |
| Corindus Reports Fourth Quarter and Full Year 2017 Results
finance.yahoo.com - March 14 at 5:32 PM |
| Corindus Vascular Robotics (CVRS) Appoints James Tobin to Board - StreetInsider.com
www.streetinsider.com - March 13 at 6:12 PM |
| Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018
finance.yahoo.com - March 13 at 6:12 PM |
| James R. Tobin Joins Corindus Board of Directors
finance.yahoo.com - March 13 at 9:56 AM |
| Corindus to Present at Cowen Health Care Conference
finance.yahoo.com - March 12 at 5:23 PM |
| Corindus Vascular Robotics Inc (CVRS) Short Interest Update
www.americanbankingnews.com - March 9 at 6:25 PM |
| Blog Exposure - FDA Approves First Automated Robotic Movement in technIQ(TM) Series for Corindus’ CorPath GRX Platform
finance.yahoo.com - March 7 at 9:44 AM |
| Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform
finance.yahoo.com - March 5 at 9:53 AM |
| Corindus Vascular Robotics Inc (CVRS) Sees Significant Increase in Short Interest
www.americanbankingnews.com - February 27 at 6:00 PM |
| Delray Beach Medical Center Performs First Robotic-Assisted Peripheral Vascular Intervention Using Corindus CorPath® GRX System Following FDA Clearance
finance.yahoo.com - February 22 at 9:24 AM |
| Corindus Vascular Robotics (CVRS) Reports FDA Clearance for CorPath GRX System in Peripheral Vascular Interventions
www.streetinsider.com - February 20 at 9:11 AM |
| Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions
finance.yahoo.com - February 20 at 9:11 AM |
 | Free Research Reports on These Medical Equipment Stocks -- Corindus Vascular Robotics, Myomo, InspireMD, and MiMedx
www.bizjournals.com - January 31 at 9:16 AM |
| Corindus Vascular Robotics (CVRS) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 29 at 10:10 PM |
| Corindus Vascular Robotics Inc (CVRS) Sees Significant Growth in Short Interest
www.americanbankingnews.com - January 24 at 6:08 PM |
| Corindus Vascular Robotics (CVRS) Sees Q4 Revenue of $4-$4.2M
www.streetinsider.com - January 24 at 9:27 AM |
| Corindus Announces Preliminary Fourth Quarter and Full Year 2017 Revenue
finance.yahoo.com - January 24 at 9:27 AM |
| Corindus Vascular Robotics (CVRS) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 12 at 8:50 PM |
| Detailed Research: Economic Perspectives on Athersys, Repros Therapeutics, GCP Applied Technologies, IDACORP, Mobile Mini, and Corindus Vascular Robotics — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - January 4 at 8:53 AM |
 | Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary ... - Business Wire (press release)
www.businesswire.com - January 2 at 5:47 PM |
| Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities
finance.yahoo.com - January 2 at 5:47 PM |
| ETFs with exposure to Corindus Vascular Robotics, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 4:34 PM |
| Corindus Announces First Commercial Installation of CorPath - Business Wire (press release)
www.businesswire.com - December 15 at 6:34 PM |
| Corindus Vascular Robotics (CVRS) Reports First Commercial Installation of CorPath GRX System Outside of US - StreetInsider.com
www.streetinsider.com - December 15 at 6:34 PM |
| Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
finance.yahoo.com - December 14 at 8:57 AM |
| ETFs with exposure to Corindus Vascular Robotics, Inc. : December 11, 2017
finance.yahoo.com - December 11 at 4:59 PM |
| Corindus Partners with Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians
finance.yahoo.com - December 1 at 4:15 PM |
| ETFs with exposure to Corindus Vascular Robotics, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 4:48 PM |
| Short Interest in Corindus Vascular Robotics Inc (CVRS) Declines By 3.7%
www.americanbankingnews.com - November 27 at 9:56 PM |
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Corindus Vascular Robotics (NYSEAMERICAN CVRS) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
